iw-3300
Small moleculeexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jan 18, 2022 (NCT05188261)
Timeline
Indications
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05740007 | Phase 2 | Mar 28, 2023 | Ironwood Pharmaceuticals |
| NCT05362695 | Phase 1 | May 17, 2022 | Ironwood Pharmaceuticals |
| NCT05188261 | Phase 1 | Jan 18, 2022 | Ironwood Pharmaceuticals |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Ironwood Pharmaceuticals | For profit | 3 | 3 | 2 | 2022 |
1 organizations
Page 1 / 1